About this trial
In this project, the investigators aim to investigate the imaging approaches for breast cancer-related secondary lymphedema. The clinical study aims to optimize the conventional MRI methods for mapping lymphedema and assess the post-surgical therapeutic effects in longitudinal follow-up studies. Additionally, a normal imaging database of lymphedema MRI images will be established for future reference. For pre-clinical animal study, investigators aim to develop and integrate two novel MRI methods, including free water elimination diffusion MRI and diffusion kurtosis MRI techniques. By integrating clinical and pre-clinical studies, the investigators aim to establish a precise imaging tool for evaluating the therapeutic effects of lymphedema for following translational applications.
Eligibility criteria
Qualifiers
adults with breast cancer related lymphedema
Disqualifiers
children younger than 20 years old
pregnancy
The cardiac implantable electronic device (CIED) such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.
Metallic intraocular foreign bodies.
Trial design
Treatments tested in this trial
- Diffusion magnetic resonance imaging
Treatment groups
Locations
1Sponsors and collaborators
National Taiwan University Hospital
Lead sponsor
National Health Research Institutes, Taiwan
Collaborator